Doctor's urgent warning about the huge mistake everyone is making with their eyes: 'You need to stop'
Dr Fraser, an eye doctor from Detroit, has racked up more than 2.2million views on TikTok after interviewing his colleagues about the worst thing patients do to their eyes.
Their answers were unanimous.
'Eye rubbing,' one optometrist warned in the clip.
'You need to stop. Don't rub your eyes.'
However, instead of banning the action altogether she offered a practical, and much safer, alternative.
'Please, for the love of God, if you need to rub your eye, instead of rubbing the eyeball, rub the bone,' she advised.
'It'll scratch the itch, but it will put you at less risk of diseases like keratoconus.'
Keratoconus is a progressive eye condition where the cornea (the clear front surface of the eye) thins and bulges into a cone shape.
This can distort vision, and in severe cases requires surgery or corneal transplants.
Eye rubbing, experts say, is a major risk factor.
Another optometrist in Dr Fraser's clinic added that the habit doesn't just damage the eye itself, it can also speed up the ageing process around them.
'It makes your skin loose, don't do it,' she said, warning that the delicate tissue around the eyes is particularly prone to stretching and wrinkling.
A third specialist kept it simple and very direct.
'Don't rub your eyes,' she said.
Worryingly, eye rubbing isn't the only issue Dr Fraser's team flagged. One colleague pointed out that many don't blink enough, especially when glued to screens.
'Patients will be working on a computer, reading, students will be studying, and they're just too focused on what they're doing and they don't blink,' he said.
'I'm starting to see kids coming in with lid issues and dryness, and I think if you just practice blinking you'll save yourself a lot of hassle.'
Experts recommend taking regular breaks from screens, consciously blinking more often, and if your eyes feel itchy, gently pressing on the bony orbital rim rather than the eyeball itself.
Dr Fraser's video has struck a chord with viewers, many of whom admitted they were guilty of both bad habits, and others already suffering the negative effects.
'Yep, I have keratoconus,' one wrote.
'I can attest that due to allergies and being uninformed, I rubbed my eyes and now my left eye has it and I have zero clue how to fix or if there is a fix.'
'As soon as the rubbing was mentioned I had an eye itch. It's like it knew,' another added.
'Me blinking a million times after watching the video,' a viewer said in jest.
'I have keratoconus, pleeeease don't rub your eyes.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
2 minutes ago
- BBC News
Man who fired hundreds of rounds at CDC HQ was angry at Covid vaccines
A man who fired hundreds of rounds of ammunition at the US Centers for Disease Control and Prevention (CDC) headquarters last week had expressed distrust of the Covid-19 vaccine, investigators officer David Rose, 33, who graduated from the police academy in March, died in hospital after he was wounded. No civilians were injured in the 8 August shooting in Atlanta, say he was shot by Patrick Joseph White, 30, who died from "a self-inflicted gunshot wound".The CDC tracks illness outbreaks in the US and touted vaccinations during the pandemic - a position that has been heavily criticised by vaccine sceptics. Speaking to reporters on Tuesday, Georgia Bureau of Investigations Director Chris Hosey said 500 shell casings were recovered from the scene, while its believed 200 rounds hit six buildings in the CDC complex. Five firearms were also recovered, he gunman had also "verbalised thoughts of suicide" before the shooting, Hosey said, adding that investigators had uncovered written evidence of his discontent with Covid-19 vaccines. He reportedly blamed the vaccine for making him depressed and County Police Officer David Rose was fatally shot when he responded to reports of an active shooter at the CDC precinct shortly before 17:00 local time on Friday. Rose, a former Marine who had served in Afghanistan, died in hospital after he was employees or civilians were hurt and rounds fired by police officers did not strike the the gunman, Hosey said. FBI Special Agent in Charge Paul Brown said federal Swat teams cleared the CDC campus after the shooting to ensure no victims were inside. A nearby daycare was evacuated and the children there were safely reunited with their said the shooter broke into a safe at his family home to access firearms. The weapons belonged to his father and were secured, but White was able force his way into the safe. Hosey said the gunman's family has fully cooperated with their Monday, US Department of Health and Human Services (HHS) Secretary Robert F Kennedy Jr visited the CDC's Atlanta campus and met privately with the deceased officer's widow. Kennedy offered his deepest condolences and "reaffirmed the agency's commitment to honoring Officer Rose's bravery, sacrifice, and service to the nation", HHS said Monday."We are deeply saddened by the tragic shooting at CDC's Atlanta campus that took the life of officer David Rose," Kennedy wrote Friday on X. "We stand with his wife and three children and the entire CDC family."
Daily Mail
2 hours ago
- Daily Mail
Prescription pills are being laced with synthetic opioid that is 40 times stronger than fentanyl
A synthetic drug more than 40 times stronger than fentanyl has infiltrated the US drug supply, with federal data estimating more than 2,000 Americans have already been killed. Nitazenes are a group of compounds developed in the 1950s as an opioid pain reliever, but they never made it to patients because of the extremely high risk of overdose. In addition to being stronger than fentanyl, it's about 100 times stronger than morphine. However, recently, the illegal lab-made compounds are increasingly being pressed into counterfeit pills that buyers believe are legitimate pharmaceuticals, such as Xanax or oxycodone. What they might not know is that nitazenes have been found in at least 4,300 law enforcement-led drug seizures since 2019. They are often mixed in with other counterfeit or illegal drugs, including opioid pills, heroin, fentanyl and methamphetamine. Earlier this year, 22-year-old Lucci Reyes-McCallister died after taking what he believed was a Xanax pill. The Texas native had no idea the fake medication was laced with a type of nitazene 25 times deadlier than fentanyl. Just six months later, his friend Hunter Clement, 21, suffered the same fate after swallowing a counterfeit Percocet containing nitazenes. In both cases, several doses of Narcan, the opioid overdose reversal agent, were not enough. Nitazenes were never widely used until now, with a surge leaving the CDC and law enforcement at a major disadvantage. They gained popularity rapidly starting in 2019, evading officials' limited testing capabilities, leading to underreported overdoses. There are dozens of analogs, or modified versions of nitazenes, that have varying levels of potency. Potency also varies among batches, depending on the type of nitazene analog lacing the drugs, and uneven mixing means one pill may have a lethal dose while another has barely any. Compared to fentanyl, the analogs butonitazene and etodesnitazene are 25 to 50 percent as strong, while isotonitazene (ISO) is five to 10 times stronger. The most extreme variants, N-pyrrolidino protonitazene and N-pyrrolidino etonitazene, are up to 25 times stronger and up to 43 times stronger, respectively. Nitazenes first appeared in the US as fentanyl, which has killed an average of 70,000 Americans annually over the past three years. At about the same time, nitazenes appeared in Europe and the UK, where they have spread quickly and have killed nearly a thousand people. From 2020 to 2021, Tennessee saw a notable jump in nitazene-related deaths. It was the first cluster of deaths linked to the synthetic drug the country had seen and caught the CDC's attention. Fatal overdoses there jumped from 10 to 42. Most of those deaths involved multiple substances, including fentanyl and meth. ISO drove most of the nitazene-linked deaths. From May 2024 to 2025, Houston, Texas DEA agents reported 15 nitazene overdose deaths in people ranging in age from 17 to 59. William Kimbell, the special agent in charge of the division, said: 'We started seeing it in the Houston area, our first seizure was in 2022. 'And kind of the reason we're talking now is over the last year we have seen a pretty dramatic increase in its usage in Houston and the surrounding area.' Kimbell added that the agency has seen a 15 percent increase in nitazene-related overdoses in Houston and surrounding areas between November 2024 and February 2025. Reyes-McCallister died in the Houston area on January 26. His counterfeit Xanax had been laced with N-pyrrolidino protonitazene. His mother Grey McCallister told the New York Post: 'It was the first time I'd ever heard of it. 'It took them seven rounds of Narcan to try to revive him.' Clement's mother was equally as unacquainted with the drug. She said: 'I told my husband, "I feel like that could be what Hunter died from."' The raw chemicals to make the drugs are believed to come from China and India. Chemical companies there are able to synthesize the compounds at scale in a relatively easy process of three or four steps before the substance is smuggled to the UK, Europe and the US. Compared to countries in Asia, Europe, South America, as well as Australia, New Zealand, and the Pacific islands, the US has the widest range of nitazene analogs and the most fatalities. In the US, drug seizures are ticking up. The Drug Enforcement Administration has reportedly seized nitazenes more than 4,000 times between 2019 and 2024. Andrew Renna, Assistant Port Director for Cargo Operations at JFK Airport in New York City said in May: 'Earlier this month, we seized almost a pound of nitazene that was going to a private residence in South Carolina. It was shipped from the United Kingdom. 'Unfortunately, here at JFK, we're seeing xylazine and nitazenes at least a few times a week in quantities ranging from just a few grams to upwards of a pound or more.' Nitazenes often evade detection in standard toxicology tests, allowing them to fly under the radar of public health officials and medical examiners. Many routine drug screens do not include tests for these synthetic opioids, meaning overdoses and deaths linked to nitazenes may be misclassified or underreported. This lack of visibility delays public health responses, leaving communities unaware of the growing threat on their streets. Nitazene overdose can lead to severe and life-threatening symptoms, including slow or shallow breathing, which indicates respiratory depression, a hallmark of opioid toxicity. If a good Samaritan passing by or a law enforcement officer only has one or two doses on them, it may not be enough to save the person's life.
Reuters
2 hours ago
- Reuters
US FDA approves Insmed's drug as first treatment for a chronic lung disease
Aug 12 (Reuters) - The U.S. Food and Drug Administration has approved Insmed's (INSM.O), opens new tab oral drug for a type of lung disease, the company said on Tuesday, making it the first treatment for the chronic condition. Shares of the New Jersey-based drugmaker rose 6% in morning trade. Insmed's drug, branded as Brinsupri, targets non-cystic fibrosis bronchiectasis, a chronic lung condition characterized by permanently damaged airways, leading to persistent cough and excessive mucus production. The condition affects 350,000 to 500,000 adults in the U.S., according to the American Lung Association. Brinsupri works by blocking certain inflammatory enzymes in white blood cells, preventing them from becoming overactive and damaging the lungs. Earlier treatments for the condition focused on controlling symptoms by using antibiotics, surgery or devices such as flutter valves to clear the airways. Insmed's application was based on a late-stage trial involving 1,680 adult and 41 adolescent patients, with the drug significantly reducing the frequency of respiratory symptoms such as chronic cough. The drug was found to be safe and well-tolerated at the two tested doses of 10 milligrams and 25 milligrams. TD Cowen analyst Ritu Baral expects the drug to reach peak sales of $3.7 billion in the United States by 2031. Brinsupri has the potential to drive future profitability for the company, she said. Rival treatments in development for the chronic lung condition include AstraZeneca's (AZN.L), opens new tab benralizumab and Zambon's inhaled antibiotic therapy CMS I-neb. This marks the second FDA approval for Insmed following Arikayce, which the agency cleared in 2018 to treat a chronic lung infection caused by bacteria commonly found in soil and water.
